Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04296006 · ClinicalTrials.gov registry record · Early Phase 1

Neurobehavioral Mechanisms of Cocaine Choice

A Early Phase 1 study, sponsored by Joshua A. Lile, Ph.D..

Completed
Registry status
Early Phase 1
Development phase
15
Enrollment target

NCT04296006 is a Early Phase 1 study that has completed, run by Joshua A. Lile, Ph.D.. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04296006, a Early Phase 1 study, has completed, sponsored by Joshua A. Lile, Ph.D..

COMPLETED
Registry status
Early Phase 1
Development phase
15 participants
Enrollment target

Study Summary

The objective of this protocol is to use a drug-vs-money choice task, reinforcement learning modeling and fMRI to determine the neurobehavioral and neurobiological decision-making "profile" associated with the decision to take cocaine and the reduced cocaine choice that occurs during a behavioral intervention (alternative money reinforcer) that models contingency management.

Interventions

  • BEHAVIORAL Money
  • DRUG Cocaine HCl

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-01-15
Est. Completion 2025-02-01
Phase Early Phase 1

Sponsor

Joshua A. Lile, Ph.D.

7 total trials

What the Registry Record Tells You About NCT04296006

The ClinicalTrials.gov registry entry for NCT04296006 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joshua A. Lile, Ph.D., which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Money is the first listed.

NCT04296006 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04296006 about?

NCT04296006 is a clinical study titled "Neurobehavioral Mechanisms of Cocaine Choice". The objective of this protocol is to use a drug-vs-money choice task, reinforcement learning modeling and fMRI to determine the neurobehavioral and neurobiological decision-making "profile" associated with the decision to take cocaine and the reduced cocaine choice that occurs during a behavioral in...

What is the current status of trial NCT04296006?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2021-01-15. Estimated completion is 2025-02-01.

What interventions are being tested in trial NCT04296006?

The interventions under investigation include: Money (BEHAVIORAL), Cocaine HCl (DRUG).

Who is sponsoring clinical trial NCT04296006?

This trial is sponsored by Joshua A. Lile, Ph.D., which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.